Literature DB >> 15655254

Nuclear receptor coregulators are new players in nervous system development and function.

Eijun Nishihara1, Bert W O'Malley, Jianming Xu.   

Abstract

Steroid/thyroid hormones and their cognate nuclear receptors (NRs) play important roles in nervous system development and function. The spatial and temporal gene expression that is regulated by NRs in the nervous system requires transcriptional intermediary coregulators, designated as coactivators and corepressors. These coregulators enhance or repress transcriptional activity of NRs and modulate their target gene transcription. Recent progress has largely advanced our understanding of the molecular mechanisms by which NR coregulators function in the nervous system. This article summarizes our current knowledge about the molecular mechanisms, expression patterns, and biological functions of NR coactivators, such as the p160 steroid receptor coactivator family, CBP, p300, BRG1, TRAP220, PGC-1alpha, ERAP140, NIX1, and E6-AP, as well as corepressors such as NCoR and SMRT. Accumulated findings suggest that the functional spectrum of NR coregulators is much broader than was initially speculated, and these coregulators likely contribute to many physiological aspects of nervous system development and function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15655254     DOI: 10.1385/MN:30:3:307

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  134 in total

1.  Expression and hormonal regulation of coactivator and corepressor genes.

Authors:  S Misiti; L Schomburg; P M Yen; W W Chin
Journal:  Endocrinology       Date:  1998-05       Impact factor: 4.736

2.  Null mutation of mCOUP-TFI results in defects in morphogenesis of the glossopharyngeal ganglion, axonal projection, and arborization.

Authors:  Y Qiu; F A Pereira; F J DeMayo; J P Lydon; S Y Tsai; M J Tsai
Journal:  Genes Dev       Date:  1997-08-01       Impact factor: 11.361

Review 3.  Corticosteroid receptors in the brain: gene targeting studies.

Authors:  Christoph Kellendonk; Peter Gass; Oliver Kretz; Günther Schütz; François Tronche
Journal:  Brain Res Bull       Date:  2002-01-01       Impact factor: 4.077

Review 4.  Adrenal steroid receptors and actions in the nervous system.

Authors:  B S McEwen; E R De Kloet; W Rostene
Journal:  Physiol Rev       Date:  1986-10       Impact factor: 37.312

5.  Acute mixed lineage leukemia with an inv(8)(p11q13) resulting in fusion of the genes for MOZ and TIF2.

Authors:  J Liang; L Prouty; B J Williams; M A Dayton; K L Blanchard
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

6.  Coactivators for the orphan nuclear receptor RORalpha.

Authors:  G B Atkins; X Hu; M G Guenther; C Rachez; L P Freedman; M A Lazar
Journal:  Mol Endocrinol       Date:  1999-09

7.  Thyroid hormone exerts site-specific effects on SRC-1 and NCoR expression selectively in the neonatal rat brain.

Authors:  Eric A Iannacone; Arthur W Yan; Kelly J Gauger; Amy L S Dowling; R Thomas Zoeller
Journal:  Mol Cell Endocrinol       Date:  2002-01-15       Impact factor: 4.102

Review 8.  Brain corticosteroid receptor balance in health and disease.

Authors:  E R De Kloet; E Vreugdenhil; M S Oitzl; M Joëls
Journal:  Endocr Rev       Date:  1998-06       Impact factor: 19.871

9.  Steroid receptor coactivator-1 is not required for androgen-mediated sexual differentiation of spinal motoneurons.

Authors:  Douglas A Monks; Jianming Xu; Bert W O'Malley; Cynthia L Jordan
Journal:  Neuroendocrinology       Date:  2003-07       Impact factor: 4.914

10.  Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor.

Authors:  V Cavaillès; S Dauvois; F L'Horset; G Lopez; S Hoare; P J Kushner; M G Parker
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  10 in total

1.  Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines.

Authors:  Olivia Tania Hernández-Hernández; Mauricio Rodríguez-Dorantes; Aliesha González-Arenas; Ignacio Camacho-Arroyo
Journal:  Endocrine       Date:  2009-12-05       Impact factor: 3.633

Review 2.  An overview of nuclear receptor coregulators involved in cerebellar development.

Authors:  Eijun Nishihara
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

3.  Cells in behaviourally relevant brain regions coexpress nuclear receptor coactivators and ovarian steroid receptors.

Authors:  M J Tetel; N K Siegal; S D Murphy
Journal:  J Neuroendocrinol       Date:  2007-04       Impact factor: 3.627

Review 4.  Sex differences in DNA methylation may contribute to risk of PTSD and depression: a review of existing evidence.

Authors:  Monica Uddin; Levent Sipahi; Jia Li; Karestan C Koenen
Journal:  Depress Anxiety       Date:  2013-08-19       Impact factor: 6.505

5.  E6AP in the brain: one protein, dual function, multiple diseases.

Authors:  Jimmy El Hokayem; Zafar Nawaz
Journal:  Mol Neurobiol       Date:  2013-10-05       Impact factor: 5.590

Review 6.  Who's in charge? Nuclear receptor coactivator and corepressor function in brain and behavior.

Authors:  Marc J Tetel; Anthony P Auger; Thierry D Charlier
Journal:  Front Neuroendocrinol       Date:  2009-05-04       Impact factor: 8.606

Review 7.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

Review 8.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

9.  Crx activates opsin transcription by recruiting HAT-containing co-activators and promoting histone acetylation.

Authors:  Guang-Hua Peng; Shiming Chen
Journal:  Hum Mol Genet       Date:  2007-07-26       Impact factor: 6.150

10.  Thyroid hormone components are expressed in three sequential waves during development of the chick retina.

Authors:  Jeffrey M Trimarchi; Sanjiv Harpavat; Nathan A Billings; Constance L Cepko
Journal:  BMC Dev Biol       Date:  2008-10-14       Impact factor: 1.978

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.